Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation

Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation

Objective and;To evaluate the clinical value of valganciclovir in preemptive treatment of cytomegalovirus (CMV) infection after allogeneic hematopoietic stem cell transplantation (allo-HSCT) by comparing the efficacy of the drug with other conventional antiviral drugs (ganciclovir or foscarnet sodiu...

Full description

Bibliographic Details
Main Authors: LU Xuan, YAN Han, XIA Linghui
Format: Article
Language:zho
Published: Editorial Office of Journal of Third Military Medical University 2020-09-01
Series:Di-san junyi daxue xuebao
Subjects:
cytomegalovirus viremia
allogeneic hematopoietic stem cell transplantation
valganciclovir
preemptive therapy
antithymocyte globulin
Online Access:http://aammt.tmmu.edu.cn/Upload/rhtml/202005126.htm

Internet

http://aammt.tmmu.edu.cn/Upload/rhtml/202005126.htm

Similar Items